Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05045742 · ClinicalTrials.gov registry record
Prediction of Patient Deterioration Using Machine Learning
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 526
- Enrollment target
NCT05045742: Completed study, sponsored by Brigham and Women's Hospital.
NCT05045742 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 526 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05045742 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 526 participants
- Enrollment target
Study Summary
This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict patient deterioration throughout a patient's admission. This algorithm was then validated in a validation cohort.
Primary Outcome
The number of alarms fired per patient per hour
Interventions
- OTHER Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 526 participants |
| Start Date | 2021-03-20 |
| Est. Completion | 2026-02-16 |
What the finished NCT05045742 record still lists
NCT05045742 is an observational study that tracks outcomes without assigning an intervention. The registered 526 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2 is the first listed.
NCT05045742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05045742 about?
NCT05045742 is a clinical study titled "Prediction of Patient Deterioration Using Machine Learning". This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict patient deterioration throughout a patient's admission. This algorithm w...
What is the current status of trial NCT05045742?
This trial is currently completed. The enrollment target is 526 participants. The study started on 2021-03-20. Estimated completion is 2026-02-16.
What interventions are being tested in trial NCT05045742?
The interventions under investigation include: Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2 (OTHER).
Who is sponsoring clinical trial NCT05045742?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04738825 · 526 participants · NA
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
- NCT04769492 · 525 participants · NA
#ChopViolence/#ChopHIV
- NCT05260047 · 525 participants · NA
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
- NCT05620719 · 525 participants · NA
Multisite Advancement of Research on Chronic Posttraumatic Headache
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI